Sanofi News

French Regulator Links Sanofi Epilepsy Drug to Birth Defects

Up to 4,100 children in France suffered major malformations in the womb after their mothers took a treatment against epilepsy and bipolar disorders known as valproate between 1967 and 2016, France’s drug regulator said. Valproate, which has been manufactured in …

French Women Took Sanofi Epilepsy Drug Despite Risk to Fetuses: Report

More than 10,000 pregnant women in France took Sanofi’s anti-epilepsy drug Depakine between 2007 and 2014 although the risk of fetus malformation was known, according to a study quoted by French satirical weekly Le Canard Enchaine. The weekly reported that …